196 related articles for article (PubMed ID: 31253850)
1. Manassantin B shows antiviral activity against coxsackievirus B3 infection by activation of the STING/TBK-1/IRF3 signalling pathway.
Song JH; Ahn JH; Kim SR; Cho S; Hong EH; Kwon BE; Kim DE; Choi M; Choi HJ; Cha Y; Chang SY; Ko HJ
Sci Rep; 2019 Jun; 9(1):9413. PubMed ID: 31253850
[TBL] [Abstract][Full Text] [Related]
2. Antiviral Mechanisms of Saucerneol from
Song JH; Mun SH; Yang H; Kwon YS; Kim SR; Song MY; Ham Y; Choi HJ; Baek WJ; Cho S; Ko HJ
Viruses; 2023 Dec; 16(1):. PubMed ID: 38275951
[TBL] [Abstract][Full Text] [Related]
3. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production.
Liu H; Li M; Song Y; Xu W
Front Immunol; 2018; 9():2479. PubMed ID: 30410495
[TBL] [Abstract][Full Text] [Related]
4.
Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
[TBL] [Abstract][Full Text] [Related]
5. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.
Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M
Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210
[TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma.
Zhang Y; Zhu H; Huang C; Cui X; Gao Y; Huang Y; Gong W; Zhao Y; Guo S
J Cardiovasc Pharmacol; 2006 Feb; 47(2):190-5. PubMed ID: 16495755
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
8. Berberine impairs coxsackievirus B3-induced myocarditis through the inhibition of virus replication and host pro-inflammatory response.
Dai Q; He X; Yu H; Bai Y; Jiang L; Sheng H; Peng J; Wang M; Yu J; Zhang K
J Med Virol; 2021 Jun; 93(6):3581-3589. PubMed ID: 33336842
[TBL] [Abstract][Full Text] [Related]
9. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis.
Dai K; Wang Y; Tai S; Ni H; Lian H; Yu Y; Liao W; Zheng C; Chen Q; Kuver A; Li J
Cardiovasc Ther; 2018 Dec; 36(6):e12477. PubMed ID: 30380183
[TBL] [Abstract][Full Text] [Related]
10. Antiviral effects of aqueous extract from Spatholobus suberectus Dunn. against coxsackievirus B3 in mice.
Pang J; Guo JP; Jin M; Chen ZQ; Wang XW; Li JW
Chin J Integr Med; 2011 Oct; 17(10):764-9. PubMed ID: 21717161
[TBL] [Abstract][Full Text] [Related]
11. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
Stein EA; Pinkert S; Becher PM; Geisler A; Zeichhardt H; Klopfleisch R; Poller W; Tschöpe C; Lassner D; Fechner H; Kurreck J
J Infect Dis; 2015 Feb; 211(4):613-22. PubMed ID: 25193982
[TBL] [Abstract][Full Text] [Related]
12. Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury.
Dörner A; Grunert HP; Lindig V; Chandrasekharan K; Fechner H; Knowlton KU; Isik A; Pauschinger M; Zeichhardt H; Schultheiss HP
J Mol Med (Berl); 2006 Oct; 84(10):842-51. PubMed ID: 16924471
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of Paris polyphylla smith against enterovirus 71 and coxsackievirus B3 and its immune modulation.
Wang YC; Yi TY; Lin KH
Am J Chin Med; 2011; 39(6):1219-34. PubMed ID: 22083992
[TBL] [Abstract][Full Text] [Related]
14. Caboxamycin Inhibits Heart Inflammation in a Coxsackievirus B3-Induced Myocarditis Mouse Model.
Kim HG; Hillman PF; Lee YJ; Jeon HE; Lim BK; Nam SJ
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793559
[TBL] [Abstract][Full Text] [Related]
15. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
[TBL] [Abstract][Full Text] [Related]
16.
Fu Q; Gao L; Fu X; Meng Q; Lu Z
J Microbiol Biotechnol; 2019 Aug; 29(8):1230-1239. PubMed ID: 31370111
[No Abstract] [Full Text] [Related]
17. Involvement of Endoplasmic Reticulum Stress-Mediated C/EBP Homologous Protein Activation in Coxsackievirus B3-Induced Acute Viral Myocarditis.
Cai Z; Shen L; Ma H; Yang J; Yang D; Chen H; Wei J; Lu Q; Wang DW; Xiang M; Wang J
Circ Heart Fail; 2015 Jul; 8(4):809-18. PubMed ID: 25985795
[TBL] [Abstract][Full Text] [Related]
18. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
[TBL] [Abstract][Full Text] [Related]
19. Antiviral effects of interferon-β are enhanced in the absence of the translational suppressor 4E-BP1 in myocarditis induced by Coxsackievirus B3.
Burke JD; Sonenberg N; Platanias LC; Fish EN
Antivir Ther; 2011; 16(4):577-84. PubMed ID: 21685545
[TBL] [Abstract][Full Text] [Related]
20.
Yu X; Zhang Y; Pei K; Tan J; Tian H; Xu T; Liu F; Peng N; Huang Y; Huang X; Huang X; Wu J; Liu Q; Zeng L; Hua W; Huang X
Food Funct; 2023 May; 14(9):4129-4142. PubMed ID: 37042256
[No Abstract] [Full Text] [Related]
[Next] [New Search]
